CX3CL1 and neoplasm: CX3CR1+ T-cell subsets can be identified in tumors (15, 17); however, it remains unclear whether they migrate from secondary lymphoid organs via the CX3CR1/CX3CL1 axis or directly differentiate from CX3CR1− CD8+ T cells in the tumor microenvironment.